ACTIVE

BIOTECH-INVEST

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

204 k €

+126.6% YoY

Gross margin

348,4 k €

+66.3% YoY

Equity

1,7 M €

+13.2% YoY

What does BIOTECH-INVEST do?

BIOTECH-INVEST is a Private limited company incorporated in 2002. Its main activity is: Public relations and communication activities. Its registered office is in Lievegem.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0476.881.001

Incorporation

12/02/2002

Legal form

Private limited company

Registered office

Brugstraat 48
9921 Lievegem · FlandreSee on map

Contributed capital

534 300,00 €

Latest accounts

30/09/2025

Activities (NACE)

70210Public relations and communication activities· main 73300Advertising and market research 74151Specialised design activities 64200Activities of holding companies 64210Activities of holding companies 74141Specialised design activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	348,4 k €	+66.3%	209,6 k €	-9.2%	230,7 k €	+5.0%	219,8 k €	+6.7%	205,9 k €	+0.4%	205,1 k €	+18.6%	173 k €	-26.3%	234,8 k €	-8.1%	255,5 k €	-14.3%	298,2 k €	+19.8%	249 k €	+55.3%	160,3 k €	+3.2%	155,4 k €	-2.1%	158,7 k €	+2.2%	155,2 k €	+1.9%	152,3 k €	+2.4%	148,8 k €	-15.3%	175,5 k €	+26.4%	138,9 k €	+0.2%	138,6 k €
EBITDA	344,6 k €	+67.4%	205,8 k €	-9.5%	227,4 k €	+4.3%	217,9 k €	+7.3%	203,1 k €	+0.4%	202,3 k €	+18.8%	170,3 k €	+8.1%	157,5 k €	-14.9%	185,1 k €	-18.2%	226,4 k €	+24.4%	182 k €	+98.2%	91,8 k €	+6.7%	86 k €	-7.5%	93 k €	+1.2%	92 k €	+2.7%	89,6 k €	+3.5%	86,5 k €	-26.4%	117,6 k €	+41.9%	82,9 k €	-1.0%	83,7 k €
Operating result	302,8 k €	+84.6%	164,1 k €	-9.2%	180,8 k €	+0.7%	179,6 k €	-5.2%	189,4 k €	+0.5%	188,3 k €	+27.6%	147,6 k €	+6.7%	138,4 k €	-16.7%	166,2 k €	-17.1%	200,4 k €	+19.5%	167,7 k €	+116%	77,5 k €	+1.9%	76,1 k €	-12.6%	87 k €	+4.3%	83,4 k €	+0.8%	82,7 k €	+3.7%	79,8 k €	-26.5%	108,6 k €	+38.7%	78,3 k €	-3.5%	81,2 k €
Net result	204 k €	+127%	90 k €	-6.3%	96,1 k €	-72.9%	355 k €	+189%	122,9 k €	+2.0%	120,5 k €	+25.1%	96,3 k €	+28.6%	74,9 k €	-16.2%	89,4 k €	-48.5%	173,6 k €	+68.6%	103 k €	+82.3%	56,5 k €	-5.1%	59,5 k €	-64.9%	169,5 k €	+198%	57 k €	+3.9%	54,9 k €	-2.1%	56 k €	-20.0%	70 k €	+32.7%	52,8 k €	+11.7%	47,2 k €
Balance sheet
Equity	1,7 M €	+13.2%	1,5 M €	-0.3%	1,5 M €	+6.6%	1,5 M €	+1.3%	1,4 M €	+9.4%	1,3 M €	+10.1%	1,2 M €	+8.8%	1,1 M €	+7.4%	1 M €	+9.6%	928,8 k €	+23.0%	755,2 k €	+15.8%	652,2 k €	-0.1%	653 k €	+10.0%	593,5 k €	+40.0%	424 k €	+15.5%	367 k €	+17.6%	312,1 k €	+21.9%	256,1 k €	+37.6%	186,1 k €	+39.6%	133,3 k €
Total assets	2,2 M €	-10.7%	2,5 M €	+4.3%	2,4 M €	+5.1%	2,3 M €	+20.9%	1,9 M €	+9.9%	1,7 M €	+10.3%	1,5 M €	+7.9%	1,4 M €	-4.5%	1,5 M €	+6.2%	1,4 M €	+20.1%	1,2 M €	+29.3%	907,7 k €	-1.8%	924,5 k €	+9.4%	844,9 k €	+43.4%	589 k €	+26.7%	464,9 k €	+10.7%	419,9 k €	+16.5%	360,4 k €	+14.7%	314,2 k €	+43.8%	218,4 k €
Cash	780,8 k €	-24.1%	1 M €	-24.9%	1,4 M €	+45.6%	941,7 k €	-28.9%	1,3 M €	+23.1%	1,1 M €	+12.3%	958 k €	-17.6%	1,2 M €	-2.9%	1,2 M €	+15.4%	1 M €	+12.1%	925,7 k €	+38.3%	669,3 k €	-2.4%	686 k €	+5.3%	651,2 k €	+67.3%	389,1 k €	+49.7%	260 k €	+24.9%	208,1 k €	+5028%	4,1 k €	-55.6%	9,1 k €	+718%	1,1 k €
Debts	435,7 k €	-50.9%	887,9 k €	+12.0%	792,6 k €	-0.0%	792,9 k €	+88.0%	421,8 k €	+11.7%	377,6 k €	+10.4%	341,9 k €	+6.1%	322,1 k €	-30.5%	463,5 k €	-0.7%	466,9 k €	+14.4%	408,2 k €	+65.8%	246,2 k €	-6.9%	264,3 k €	+9.4%	241,5 k €	+50.7%	160,3 k €	+68.5%	95,1 k €	-9.5%	105,1 k €	+3.3%	101,8 k €	-19.0%	125,6 k €	+51.6%	82,8 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 6 ended

Active mandates

Kathleen LAMMENS

Director

Active

Stefaan Fernand HEYVAERTS

Director

Active

Ended mandates

Kathleen LAMMENS

Manager · since 01 octobre 2018

Ended

KATLEEN LAMMENS

Director

Ended

STEFAAN HEYVAERTS

Director · until 31 décembre 2022

Ended

STEFAAN HEYVAERTS

Director

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2024	01/10/2023	01/10/2022	01/10/2021	01/10/2020	01/10/2019
Closing of the financial year	30/09/2025	30/09/2024	30/09/2023	30/09/2022	30/09/2021	30/09/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/03/2026	28/04/2025	08/04/2024	04/04/2023	07/04/2022	01/04/2021
General meeting	28/03/2026	29/03/2025	30/03/2024	25/03/2023	26/03/2022	15/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/09/2025	28/03/2026	30/03/2026	Dutch	PDF
Micro model	30/09/2024	29/03/2025	28/04/2025	Dutch	PDF
Micro model	30/09/2023	30/03/2024	08/04/2024	Dutch	PDF
Abridged model	30/09/2022	25/03/2023	04/04/2023	Dutch	PDF
Abridged model	30/09/2021	26/03/2022	07/04/2022	Dutch	PDF
Abridged model	30/09/2020	15/03/2021	01/04/2021	Dutch	PDF
Micro model	30/09/2019	28/03/2020	15/04/2020	Dutch	PDF
Micro model	30/09/2018	30/03/2019	29/04/2019	Dutch	PDF
Micro model	30/09/2017	31/03/2018	26/04/2018	Dutch	PDF
Abridged model	30/09/2016	25/03/2017	27/03/2017	Dutch	PDF
Abridged model	30/09/2015	26/03/2016	01/04/2016	Dutch	PDF
Abridged model	30/09/2014	28/03/2015	30/03/2015	Dutch	PDF
Abridged model	30/09/2013	29/03/2014	31/03/2014	Dutch	PDF
Abridged model	30/09/2012	30/03/2013	11/04/2013	Dutch	PDF
Abridged model	30/09/2011	31/03/2012	03/04/2012	Dutch	PDF
Abridged model	30/09/2010	26/03/2011	07/04/2011	Dutch	PDF
Abridged model	30/09/2009	27/03/2010	29/03/2010	Dutch	PDF
Abridged model	30/09/2008	28/03/2009	21/04/2009	Dutch	PDF
Abridged model	30/09/2007	29/03/2008	08/04/2008	Dutch	PDF
Abridged model	30/09/2006	31/03/2007	26/04/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 6 ended

Active mandates

Kathleen LAMMENS

Director

Active

Stefaan Fernand HEYVAERTS

Director

Active

Ended mandates

Kathleen LAMMENS

Manager · since 01 octobre 2018

Ended

KATLEEN LAMMENS

Director

Ended

STEFAAN HEYVAERTS

Director · until 31 décembre 2022

Ended

STEFAAN HEYVAERTS

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/11/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares08/10/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other03/06/2005
DIVERSEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025204 k €↑
2024
Annual accounts 202490 k €↓
2023
Annual accounts 202396,1 k €↓
2022
Annual accounts 2022355 k €↑
2021
Annual accounts 2021122,9 k €↑
2020
Annual accounts 2020120,5 k €↑
2019
Annual accounts 201996,3 k €↑
2018
Annual accounts 201874,9 k €↓
2017
Annual accounts 201789,4 k €↓
2016
Annual accounts 2016173,6 k €↑
2015
Annual accounts 2015103 k €↑
2014
Annual accounts 201456,5 k €↓
2013
Annual accounts 201359,5 k €↓
2012
Annual accounts 2012169,5 k €↑
2011
Annual accounts 201157 k €↑
2010
Annual accounts 201054,9 k €↓
2009
Annual accounts 200956 k €↓
2008
Annual accounts 200870 k €↑
2007
Annual accounts 200752,8 k €↑
2006
Annual accounts 200647,2 k €
12/02/2002
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BIOTECH-INVEST

Overview

What does BIOTECH-INVEST do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline